on the quality of life of liver transplant recipients

[1]  A. Frigo,et al.  Model for end‐stage liver disease‐sodium and survival benefit in liver transplantation , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  A. Vitale,et al.  Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? , 2012, Transplantation proceedings.

[3]  W. Hop,et al.  Liver transplantation for unresectable hepatocellular carcinoma in normal livers. , 2012, Journal of hepatology.

[4]  M. Conconi,et al.  Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury , 2012, BMC Gastroenterology.

[5]  E. Tsochatzis,et al.  Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[6]  P. Burra.  The adolescent and liver transplantation. , 2012, Journal of hepatology.

[7]  M. Zoli,et al.  Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy , 2012, European journal of gastroenterology & hepatology.

[8]  M. Ermani,et al.  The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. , 2000, Journal of hepatology.

[9]  M. Senzolo,et al.  Long‐term medical and psycho‐social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  A. Buda,et al.  Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein‐Barr virus (EBV) infection , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  G. Corrao,et al.  Outcome variables in the evaluation of alcoholics' treatment: lessons from the Italian Assessment of Alcoholism Treatment (ASSALT) Project. , 1999, Alcohol and alcoholism.

[12]  M. Dam,et al.  18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation. , 1999, Transplantation proceedings.

[13]  A. Floreani,et al.  Bone metabolism in orthotopic liver transplantation: a prospective study. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  M. Dam,et al.  Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. , 1998, Journal of hepatology.

[15]  A. Floreani,et al.  Liver transplantation and pregnancy , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  A. Floreani,et al.  Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. , 1995, Journal of hepatology.

[17]  P. Burra,et al.  The effects of ethanol, 3,5,3'-triiodothyronine (T3) and oestradiol (E2) on thyroid hormone nuclear receptor expression in human hepatocyte primary cultures. , 1995, Alcohol and alcoholism.

[18]  M. Plebani,et al.  Laboratory test scores to aid identification of primary nonfunction of liver transplants. , 1995, Clinical chemistry.

[19]  D. Adams,et al.  Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease , 1994, Hepatology.

[20]  E. Baldi,et al.  Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. , 1993, The Italian journal of gastroenterology.

[21]  D. Nitti,et al.  Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis , 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  J. Neuberger,et al.  Detection of circulating intercellular adhesion molecule–1 in chronic liver diseases , 1992, Hepatology.

[23]  D. Adams,et al.  Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? , 1992, Gut.

[24]  F. Farinati,et al.  [Peptic ulcer and liver cirrhosis. Clinico-epidemiologic considerations]. , 1990, Minerva medica.

[25]  R. Freeman,et al.  Trends in liver transplantation 2011. , 2012, Journal of hepatology.

[26]  P. Bossuyt,et al.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.

[27]  F. Farinati,et al.  Zinc, iron, and peroxidation in liver tissue , 2007, Biological Trace Element Research.

[28]  E. Baldi,et al.  Energy expenditure (EE) and substrate utilization (SU) in the perioperative period in orthotopic liver transplantation (OLTX). , 1995, Roczniki Akademii Medycznej w Bialymstoku.

[29]  P. Burra,et al.  PRESENTAZIONE DI UN TRIAL RANDOMIZZATO PLURICENTRICO SCLEROTERAPIA VS. LEGATURA ELASTICA DELLE VARICI ESOFAGEE NEL MALATO CIRROTICO CANDIDATO AL TRAPIANTO DI FEGATO CON SANGUINAMENTO PREGRESSO IN ATTO , 1994 .